Summit BHC has had its credit outlook revised from positive to negative following an out-of-court debt restructuring.
In September 2025, the Franklin, Tennessee-based behavioral health facility operator completed a distressed exchange transaction, avoiding bankruptcy. In the same month, S&P Global Ratings gave the company a CCC+ rating with a positive outlook. In May, S&P revised its outlook to negative.
As far back as May 2025, the company faced cash flow deficits, according to an S&P Global Ratings report. At that time it faced a $30 million to $40 million cash flow deficit. Its then more favorably covered Veterans Affairs patient volume was diminishing. It was dealing with increased labor costs. It also had a debt facility due in November 2026. The company announced its “pro rata liability management exercise” in August, according to octus.com.
The distressed exchange transaction restructured about $790 million in debt. The effort also generated about $125 million in new debt financing. All told, the company holds about $1.1 billion in debt financing obligations.
S&P Global sees the exchange as tantamount to a default.
In its most recent report, S&P Global Ratings’ outlook revision “primarily reflects our expectation for sustained free cash flow deficits.”
“This pressure has been exacerbated by rising labor costs, margin pressure on new facilities (during the ramp-up phase), and high leverage and cash interest expense,” the report states. “Although management is undertaking a broad array of initiatives to increase patient volumes, occupancy rates, operational efficiency, and revenue cycle management, these may be insufficient to offset downward pressure on per-patient rates.”
Summit BHC has not responded to a request for comment.
The company was founded in 2013. It has grown into a national player in the addiction treatment and psychiatric hospital space through M&A, later shifting to de novo expansion. That shift was further bolstered by the 2024 launch of an outpatient division. The company historically focused on residential and hospital care.
An S&P Global Ratings report notes the company is in the process of closing several facilities as it focuses on “rationalization and operational restructuring.” The company appears to have parted ways with three residential facilities and two outpatient locations, based on a comparison of its current facility listing with an archived version of the same page from March 2025. All three facilities — one each in New Hampshire, New Jersey and Pennsylvania — were addiction treatment facilities.
“Reimbursement headwinds and uncertainty in the substance abuse disorder segment (about 40% of 2025 revenue) is a key factor in underperformance contributing to the free cash flow deficits,” an S&P Global Ratings report states. “Summit’s acute psychiatric facilities business (60% of 2025 revenue) is increasing revenue and performing broadly in line with our expectations.”
The report further states that the company is expected to have “a substantial free cash flow deficit in 2026 and a more modest shortfall in 2027.”
Summit BHC was acquired by Patient Square Capital in 2021, making 2026 its fifth year of its hold period. However, hold periods in the U.S. are increasing. One source puts the median hold period for PE-backed companies at six years.
“They’re kind of an older vintage when it comes to an investment for a PE group,” Ryan Kaczka, managing director of Strategique Partners, told Behavioral Health Business. “I would assume they are positioning themselves for either a recap or going to market.”
Kaczka notes that the psychiatric hospital space is seeing a lot of dealmaking at the moment. There are many changes in organization structures, with more opting for separations of real estate and operations into “opcos and propcos.” The industry also sees the benefit of quasi-monopoly status in many communities, where one hospital services a local population with little other competition.
The market is also seeing a turnover in leadership teams. In some cases, the teams that expanded these types of organizations are changing. Summit BHC named a new CEO in August 2025.
The addiction treatment space has seen operators’ success become highly dependent on payer mix and model. Companies that have invested in strong local referral networks and compliance, especially with payers, are doing well as payers ramp up scrutiny on behavioral health. This has been accelerated with the arrival of AI tools that can automate reviews at scale.
“Everyone right now is really trying to batten down the hatches on compliance,” Kaczka said. “If you don’t have the compliance and the billing set up and the referral system going, you’re dead in the water right now.”
The company also serves as another potential warning about the impact of highly leveraged behavioral health platforms amid massive U.S. interest rates increases following post-COVID-era inflation. During that time, the financial models and reimbursement realities of the behavioral health market have changed substantially.
Discovery Behavioral Health, for example, has been taken over by HPS Investment Partners. In that exchange, the company traded its equity for debt relief.
“To me, the broader sector takeaway is that behavioral health M&A is moving from a growth multiple market to a quality of earnings market,” Kaczka said. “They are asking which beds are actually profitable, how durable the referral channels are, how clean collections are, how much capex is required, how much EBITDA converts to cash, and whether there is embedded compliance, audit or recoupment risk.”